Metered dose inhaler: Past, present, and future

Surender K. Vaswani, Peter Socrates Creticos

Research output: Contribution to journalArticle

Abstract

Background: The metered dose inhaler (MDI) to treat respiratory diseases was introduced many years ago. Due to the recently proposed ban on chlorofluorocarbon (Freon) production, the survival of the conventional MDI is uncertain. It is therefore incumbent on asthma caretakers to familiarize themselves with newer versions of the inhaler. Objective: To review the different modalities of aerosolized treatment employed in the management of asthma. This article is specifically focused on issues related to MDIs, the propellants, and the modifications since its introduction. Data Source: The MEDLINE database was used to review MDI related literature in the English language. Conclusion: Dry powder inhalers (especially the multi-dose type) and Freon-free pressurized MDIs appear promising and probably will replace conventional freonpropelled pressurized MDIs when Freon is no longer available.

Original languageEnglish (US)
Pages (from-to)11-21
Number of pages11
JournalAnnals of Allergy, Asthma and Immunology
Volume80
Issue number1
StatePublished - Jan 1998

Fingerprint

Chlorofluorocarbons
Metered Dose Inhalers
Asthma
Dry Powder Inhalers
Nebulizers and Vaporizers
Information Storage and Retrieval
MEDLINE
Language
Databases

ASJC Scopus subject areas

  • Immunology and Allergy

Cite this

Metered dose inhaler : Past, present, and future. / Vaswani, Surender K.; Creticos, Peter Socrates.

In: Annals of Allergy, Asthma and Immunology, Vol. 80, No. 1, 01.1998, p. 11-21.

Research output: Contribution to journalArticle

@article{4b51045997e643ffb9773a3432e3bd4a,
title = "Metered dose inhaler: Past, present, and future",
abstract = "Background: The metered dose inhaler (MDI) to treat respiratory diseases was introduced many years ago. Due to the recently proposed ban on chlorofluorocarbon (Freon) production, the survival of the conventional MDI is uncertain. It is therefore incumbent on asthma caretakers to familiarize themselves with newer versions of the inhaler. Objective: To review the different modalities of aerosolized treatment employed in the management of asthma. This article is specifically focused on issues related to MDIs, the propellants, and the modifications since its introduction. Data Source: The MEDLINE database was used to review MDI related literature in the English language. Conclusion: Dry powder inhalers (especially the multi-dose type) and Freon-free pressurized MDIs appear promising and probably will replace conventional freonpropelled pressurized MDIs when Freon is no longer available.",
author = "Vaswani, {Surender K.} and Creticos, {Peter Socrates}",
year = "1998",
month = "1",
language = "English (US)",
volume = "80",
pages = "11--21",
journal = "Annals of Allergy, Asthma and Immunology",
issn = "1081-1206",
publisher = "American College of Allergy, Asthma and Immunology",
number = "1",

}

TY - JOUR

T1 - Metered dose inhaler

T2 - Past, present, and future

AU - Vaswani, Surender K.

AU - Creticos, Peter Socrates

PY - 1998/1

Y1 - 1998/1

N2 - Background: The metered dose inhaler (MDI) to treat respiratory diseases was introduced many years ago. Due to the recently proposed ban on chlorofluorocarbon (Freon) production, the survival of the conventional MDI is uncertain. It is therefore incumbent on asthma caretakers to familiarize themselves with newer versions of the inhaler. Objective: To review the different modalities of aerosolized treatment employed in the management of asthma. This article is specifically focused on issues related to MDIs, the propellants, and the modifications since its introduction. Data Source: The MEDLINE database was used to review MDI related literature in the English language. Conclusion: Dry powder inhalers (especially the multi-dose type) and Freon-free pressurized MDIs appear promising and probably will replace conventional freonpropelled pressurized MDIs when Freon is no longer available.

AB - Background: The metered dose inhaler (MDI) to treat respiratory diseases was introduced many years ago. Due to the recently proposed ban on chlorofluorocarbon (Freon) production, the survival of the conventional MDI is uncertain. It is therefore incumbent on asthma caretakers to familiarize themselves with newer versions of the inhaler. Objective: To review the different modalities of aerosolized treatment employed in the management of asthma. This article is specifically focused on issues related to MDIs, the propellants, and the modifications since its introduction. Data Source: The MEDLINE database was used to review MDI related literature in the English language. Conclusion: Dry powder inhalers (especially the multi-dose type) and Freon-free pressurized MDIs appear promising and probably will replace conventional freonpropelled pressurized MDIs when Freon is no longer available.

UR - http://www.scopus.com/inward/record.url?scp=0031933515&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0031933515&partnerID=8YFLogxK

M3 - Article

C2 - 9475561

AN - SCOPUS:0031933515

VL - 80

SP - 11

EP - 21

JO - Annals of Allergy, Asthma and Immunology

JF - Annals of Allergy, Asthma and Immunology

SN - 1081-1206

IS - 1

ER -